We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Fresh Whole Blood Reduces Transfusion-Related Illnesses for Pediatric Heart Surgery

By LabMedica International staff writers
Posted on 11 May 2015
The use of fresh whole blood from single donors may reduce the risk of lifelong complications for young children undergoing heart surgery.

At present, component blood consisting of blood parts such as red blood cells, platelets or plasma from multiple donors tends to be the standard form of blood used for transfusion among children undergoing heart surgery, but the use of component blood exposes children to multiple donors, and raises their risk of transfusion-related complications. More...


Critical care physicians at The Children's Hospital of Philadelphia (Philadelphia, PA, USA) assessed the blood bank records and surgical registry data from 1995 to 2010 of 4,111 pediatric patients with an average age of 94 days. Of these patients, 3,836 received fresh whole blood, while 252 received blood components due to the unavailability of fresh whole blood. Blood was obtained from daily donations 24 to 48 hours before operation, underwent standard labeling and testing for transmissible disease, was stored at 4 °C, and was delivered to the hospital the evening before operation.

The investigators found that the youngest patients whose heart procedures were complex were exposed to the highest number of blood donors, while older patients who underwent simpler heart procedures were exposed to the fewest number of blood donors. On comparing the number of blood donor exposures among children in the program with those detailed in published reports of component blood use, they found that overall the use of fresh whole blood was associated with a lower number of donor exposures. This indicated that the use of fresh whole blood can lower the risk of transfusion-related illnesses among pediatric heart surgery patients.

The authors concluded that most young patients undergoing complex surgical procedures will continue to require multiple transfusions. For those patients, they believe that their experience with the use of fresh whole blood demonstrates a consistent reduction in donor exposure compared with the exclusive use of components and potentially reduces the risks of transfusion. Their experience also demonstrates that the provision of fresh whole blood, although logistically complicated and dependent on cooperation and careful communication, is feasible as a sustainable operating protocol between a blood center, a blood bank and the pediatric cardiothoracic surgery service they support. The study was published on March 25, 2015, in the journal the Annals of Thoracic Surgery.

Related Links:

The Children's Hospital of Philadelphia 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Thyroid Test
Anti-Thyroid EIA Test
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: WashU Medicine researchers found that dozens of blood proteins shift during Alzheimer’s treatment and may help monitor the effects of the medication. (Image Credit: Matt Miller/WashU Medicine)

Blood Biomarker Patterns Could Support Monitoring of Anti-Amyloid Treatment

Patients with early-stage Alzheimer’s disease may receive anti-amyloid therapy to clear amyloid protein deposits from the brain. These treatments can slow disease progression, but they do not cure the... Read more

Molecular Diagnostics

view channel
Image: University of Florida scientists Hugh Fan, Ph.D., and John Lednicky, Ph.D., led the development of a cost-effective, accurate handheld device capable of simultaneously testing for seven different mosquito-borne viruses. (Image Credit: UF Health photo by Hannah Clark)

Portable Test Differentiates Seven Mosquito-Borne Viruses at Point of Care

Mosquito-borne viral illnesses can present with overlapping symptoms such as fever, joint pain, fatigue, and rash, making them difficult to distinguish without laboratory testing. In these settings, clinicians... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.